Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

49.0K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.0K
Retroviruses02:33

Retroviruses

14.4K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
14.4K
Subviral Agents01:29

Subviral Agents

381
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
381
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

6.7K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.7K
RNA Interference01:23

RNA Interference

27.6K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.6K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.0K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radiological phenotyping in patients with SOX10 pathogenic variants: insights into neck, brain and temporal bones abnormalities.

AJNR. American journal of neuroradiology·2026
Same author

Outcome of hemiarthroplasty to total hip arthroplasty conversion: a systematic review.

Musculoskeletal surgery·2025
Same author

The DNA-based Lassa vaccine INO-4500 confers durable protective efficacy in cynomolgus macaques against lethal Lassa fever.

Communications medicine·2024
Same author

Projections between the globus pallidus externa and cortex span motor and non-motor regions.

bioRxiv : the preprint server for biology·2024
Same author

Medium dynamic field range linear bipolar spin valve sensor through soft pinning the sensing layer.

Journal of physics. Condensed matter : an Institute of Physics journal·2024
Same author

Vertical heterostructure of graphite-MoS<sub>2</sub> for gas sensing.

Nanoscale horizons·2024

Related Experiment Video

Updated: Dec 20, 2025

A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion
07:22

A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion

Published on: August 14, 2018

6.8K

Oregano Oil and Its Principal Component, Carvacrol, Inhibit HIV-1 Fusion into Target Cells.

S Mediouni1, J A Jablonski1, S Tsuda1

  • 1Department of Immunology and Microbiology, The Scripps Research Institute, Jupiter, Florida, USA.

Journal of Virology
|May 29, 2020
PubMed
Summary

Oregano oil, specifically carvacrol and thymol, inhibits human immunodeficiency virus (HIV) entry by depleting viral membrane cholesterol. This natural compound shows potential as a safe supplement to antiretroviral therapy, possibly delaying disease progression.

Keywords:
carvacrolcholesterol depletionentry inhibitionhuman immunodeficiency virusoregano oilthymolviral membrane

More Related Videos

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
12:03

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

8.2K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.0K

Related Experiment Videos

Last Updated: Dec 20, 2025

A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion
07:22

A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion

Published on: August 14, 2018

6.8K
Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
12:03

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

8.2K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.0K

Area of Science:

  • Virology
  • Natural Product Chemistry
  • Drug Discovery

Background:

  • Oregano essential oil is recognized for its health benefits.
  • Carvacrol and thymol are primary components of oregano oil with known biological activities.
  • Viral infections, particularly HIV, remain a significant global health concern.

Purpose of the Study:

  • To investigate the antiviral activity of oregano essential oil against lentiviruses.
  • To elucidate the mechanism of action of oregano oil components against HIV.
  • To explore the potential of oregano oil as a complementary therapy for HIV.

Main Methods:

  • In vitro testing of oregano oil and its components (carvacrol, thymol) against various viruses.
  • Analysis of viral replication, virus-target cell fusion, and viral particle density.
  • Cholesterol depletion assays and rescue experiments with exogenous cholesterol.
  • Resistance evolution studies and identification of mutations in viral proteins.
  • Structure-activity relationship analysis and combination studies with antiretroviral drugs.

Main Results:

  • Oregano oil specifically inhibited lentiviruses (HIV, SIV) but not other tested viruses.
  • Carvacrol and thymol blocked HIV-target cell fusion by depleting viral envelope cholesterol, reducing virus entry.
  • Viral resistance to carvacrol involved mutations in the gp41 fusion protein, indicating a specific mechanism.
  • Carvacrol demonstrated additive effects when combined with existing antiretroviral therapies.
  • Resistance to carvacrol emerged more slowly than with some conventional drugs.

Conclusions:

  • Oregano oil, carvacrol, and thymol show significant potential as antiviral agents against HIV.
  • The mechanism involves targeting the viral envelope's cholesterol content, disrupting virus entry.
  • These natural compounds may serve as safe adjuncts to current HIV treatment, potentially mitigating resistance development and disease progression.